PD-L1 ELISA Kit
-
- Target See all PD-L1 ELISA Kits
- PD-L1 (CD274 (PD-L1))
-
Reactivity
- Human
- Detection Method
- Colorimetric
- Method Type
- Sandwich ELISA
- Detection Range
- 5.58-15000 pg/mL
- Minimum Detection Limit
- 5.58 pg/mL
- Application
- ELISA
- Purpose
- This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human B7-H1.
- Sample Type
- Cell Culture Supernatant, Plasma, Serum
- Analytical Method
- Quantitative
- Specificity
- B7H1
- Components
- plate, standard, diluent
- Material not included
- pipettes, tubes, reader
- Featured
- Discover our best selling PD-L1 ELISA Kit
- Top Product
- Discover our top product PD-L1 ELISA Kit
-
-
- Sample Volume
- 100 μL
- Assay Time
- 3 - 4 h
- Plate
- Pre-coated
- Restrictions
- For Research Use only
-
- Buffer
- 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C
-
- Target See all PD-L1 ELISA Kits
- PD-L1 (CD274 (PD-L1))
- Alternative Name
- B7H1 (PD-L1 Products)
- Synonyms
- B7-H ELISA Kit, B7H1 ELISA Kit, PD-L1 ELISA Kit, PDCD1L1 ELISA Kit, PDCD1LG1 ELISA Kit, PDL1 ELISA Kit, A530045L16Rik ELISA Kit, B7h1 ELISA Kit, Pdcd1l1 ELISA Kit, Pdcd1lg1 ELISA Kit, Pdl1 ELISA Kit, RGD1566211 ELISA Kit, CD274 molecule ELISA Kit, CD274 antigen ELISA Kit, programmed cell death 1 ligand 2 ELISA Kit, CD274 ELISA Kit, Cd274 ELISA Kit, PDCD1LG2 ELISA Kit
- Background
- B7 homolog 1 (B7-H1), also known as programmed death-ligand 1 (PD-L1) and cluster of differentiation 274 (CD274), is a 40 kDa type I transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. The binding of B7-H1 to its receptor transmits an inhibitory signal which reduces the proliferation of these CD8+ T cells at the lymph nodes.
- NCBI Accession
- NM_021893
- UniProt
- Q9EP73
- Pathways
- Cancer Immune Checkpoints
-